Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Arch Inst Cardiol Mex ; 50(6): 703-8, 1980.
Artigo em Espanhol | MEDLINE | ID: mdl-7469613

RESUMO

The relationship between obesity and hypertension is well documented within the literature. It has been demonstrated that among hypertensive children and adolescents a greater percentage are obese; among children who are obese arterial blood pressure is higher and there is a greater incidence of hypertension. As part of a prospective study of arterial blood pressure 176 children were studied of ranging in age from 5 to 8 years. The correlation between K1 and other parameters indicating the degree of obesity was calculated. The best correlation score was found using the ponderal index (r = .53; p--.001). Body weight as well as the thickness of the albow crease showed a similar correlation with blood pressure (r = .50; p--.001). The correlation with the index for ideal weight expressed as a percentage representing the excess or deficit as compared to the ideal weight by age, sex, and heighth was also statistically significant, although the r-socre was less (r = .37; p--.01). These data confirm a positive and significant relationship between K1 and indices for obesity.


Assuntos
Hipertensão/complicações , Obesidade/complicações , Criança , Pré-Escolar , Feminino , Humanos , Masculino
3.
Arch Inst Cardiol Mex ; 46(3): 317-24, 1976.
Artigo em Espanhol | MEDLINE | ID: mdl-45539

RESUMO

In order to evaluate the clinical efficacy on penbutolol (Hoe 893 d), a new adrenergic blocking agent, two groups of 10 patients (A & B) with ischemic heart disease were chosen. These were submitted to exercise testing for 3 minutes, and placebos, nitroglycerin, and propranolol were used as reference preparations. As an index of indirect consumption of oxygen we determined the maximum cardiac frequency (MCF), maximum systolic arterial pressure (MAP) and the maximum double product (MDP). An electrocardiographic control of the patients was also included to observe ST segment changes. The patients from group A received 0.8 mg. of nitroglycerin sublingual as the first treatment and 40 mg. of propranolol as the second. The patients from group B received initially a placebo P.O. and then 25 mg. of penbutolol P.O. In both groups the exercise testing was repeated 10 minutes after the administration of the first substance and 10 minutes after the second. The results showed that 25 mg. of penbutolol and 40 mg. of propranolol have similar therapeutic effects over the degree, intensity, and duration of the differences in elevation of the ST segment, MCF, MAP, and MDP when you compare the results of their own controls with those obtained with the active principle. There is no significant difference observed in the results obtained in each parameter studied between penbutolol and propranolol. During the period of this clinical study there were no undesirable collateral effects caused by the oral administration of the investigated drugs.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Angina Pectoris/tratamento farmacológico , Eletrocardiografia , Nitroglicerina/uso terapêutico , Esforço Físico , Teste de Esforço , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Consumo de Oxigênio/efeitos dos fármacos , Pembutolol/uso terapêutico , Propranolol/uso terapêutico , Distribuição Aleatória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA